[go: up one dir, main page]

AR126090A2 - ANTIBODY OR FRAGMENT BINDING TO THE ANTIGEN OF THIS, DNA MOLECULE, CLONING OR EXPRESSION VECTOR AND HOST CELL - Google Patents

ANTIBODY OR FRAGMENT BINDING TO THE ANTIGEN OF THIS, DNA MOLECULE, CLONING OR EXPRESSION VECTOR AND HOST CELL

Info

Publication number
AR126090A2
AR126090A2 ARP220101498A ARP220101498A AR126090A2 AR 126090 A2 AR126090 A2 AR 126090A2 AR P220101498 A ARP220101498 A AR P220101498A AR P220101498 A ARP220101498 A AR P220101498A AR 126090 A2 AR126090 A2 AR 126090A2
Authority
AR
Argentina
Prior art keywords
seq
antigen
antibody
cloning
host cell
Prior art date
Application number
ARP220101498A
Other languages
Spanish (es)
Inventor
W Jason Cummings
Gregory A Demopulos
Thomas Dudler
Hans Schwaeble
- Tjoelker Larry W Wilhelm
Christie L Wood
Muneshia Yabuki
Original Assignee
Omeros Corp
Univ Leicester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omeros Corp, Univ Leicester filed Critical Omeros Corp
Publication of AR126090A2 publication Critical patent/AR126090A2/en

Links

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

Un anticuerpo aislado o fragmento de unión al antígeno de este, que se une a MASP-3, que comprende una región variable de cadena pesada que comprende una HC-CDR1 establecida como SEQ ID Nº 72 (SYGMS) o SEQ ID Nº 79 (SYGIT); una HC-CDR2 establecida como SEQ ID Nº 74 (WINTYSGVPTYADDFKG); y una HC-CDR3 establecida como SEQ ID Nº 76 (GGEAMDY) o SEQ ID Nº 82 (GGDALDY); y una región variable de cadena ligera que comprende una LC-CDR1 establecida como SEQ ID Nº 153 (KSSQSLLDSDGKTYLN), SEQ ID Nº 261 (KSSQSLLDSEGKTYLN), SEQ ID Nº 262 (KSSQSLLDSAGKTYLN) o SEQ ID Nº 263 (KSSQSLLDSDAKTYLN); una LC-CDR2 establecida como SEQ ID Nº 155 (LVSKLDS); y una LC-CDR3 establecida como SEQ ID Nº 159 (KSSQSLLDSDGKTYLS) o SEQ ID Nº 160 (WQGTHFPYT).An isolated antibody or antigen-binding fragment thereof, which binds to MASP-3, comprising a heavy chain variable region comprising a HC-CDR1 set forth as SEQ ID NO: 72 (SYGMS) or SEQ ID NO: 79 (SYGIT ); an HC-CDR2 set as SEQ ID NO: 74 (WINTYSGVPTYADDFKG); and an HC-CDR3 set as SEQ ID NO: 76 (GGEAMDY) or SEQ ID NO: 82 (GGDALDY); and a light chain variable region comprising an LC-CDR1 set forth as SEQ ID NO: 153 (KSSQSLLDSDGKTYLN), SEQ ID NO: 261 (KSSQSLLDSEGKTYLN), SEQ ID NO: 262 (KSSQSLLDSAGKTYLN) or SEQ ID NO: 263 (KSSQSLLDSDAKTYLN); an LC-CDR2 set out as SEQ ID NO: 155 (LVSKLDS); and an LC-CDR3 set as SEQ ID NO: 159 (KSSQSLLDSDGKTYLS) or SEQ ID NO: 160 (WQGTHFPYT).

ARP220101498A 2016-08-01 2022-06-06 ANTIBODY OR FRAGMENT BINDING TO THE ANTIGEN OF THIS, DNA MOLECULE, CLONING OR EXPRESSION VECTOR AND HOST CELL AR126090A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662369674P 2016-08-01 2016-08-01
US202062478336P 2020-03-29 2020-03-29
US202062419420P 2020-11-08 2020-11-08

Publications (1)

Publication Number Publication Date
AR126090A2 true AR126090A2 (en) 2023-09-13

Family

ID=88197362

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP220101498A AR126090A2 (en) 2016-08-01 2022-06-06 ANTIBODY OR FRAGMENT BINDING TO THE ANTIGEN OF THIS, DNA MOLECULE, CLONING OR EXPRESSION VECTOR AND HOST CELL
ARP220101499A AR126091A2 (en) 2016-08-01 2022-06-06 ANTIBODY OR FRAGMENT BINDING TO THE ANTIGEN OF THIS, DNA MOLECULE, CLONING OR EXPRESSION VECTOR AND HOST CELL

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP220101499A AR126091A2 (en) 2016-08-01 2022-06-06 ANTIBODY OR FRAGMENT BINDING TO THE ANTIGEN OF THIS, DNA MOLECULE, CLONING OR EXPRESSION VECTOR AND HOST CELL

Country Status (1)

Country Link
AR (2) AR126090A2 (en)

Also Published As

Publication number Publication date
AR126091A2 (en) 2023-09-13

Similar Documents

Publication Publication Date Title
ECSP20024555A (en) SPECIFIC ANTIBODIES FOR CD47 AND PD-L1
PE20180480A1 (en) FACTOR XI ANTIBODIES AND METHODS OF USE
MX2025002735A (en) Altered virus
CO2019001367A2 (en) Bispecific antibody type binding proteins that specifically bind to cd3 and cd123
EA201792184A1 (en) ANTIBODIES DIRECTED AGAINST T-CELL IMMUNOGLOBULIN AND MUTIN PROTEIN 3 (TIM-3)
EA201991383A1 (en) ANTIBODIES AGAINST CTLA-4 AND WAYS OF THEIR APPLICATION
EA201990884A1 (en) ANTI-C1s ANTIBODIES AND WAYS OF THEIR APPLICATION
PH12019502298A1 (en) Monoclonal antibody to pd-l1
EA201691470A1 (en) PROTEINS CONNECTING CALLICREIN PLASMA, AND THEIR APPLICATION FOR THE TREATMENT OF HEREDITARY ANGIONEUROTIC DOMESTIC
EA201792080A1 (en) HUMANIZED ANTI-C1S ANTIBODIES AND METHODS OF THEIR APPLICATION
MX2022006461A (en) Anti-axl antibodies, antibody fragments and their immunoconjugates and uses thereof.
UY36536A (en) ANTI-CD3 ANTIBODIES, ANTI-CD123 ANTIBODIES AND BIESPECIFIC ANTIBODIES THAT SPECIFICALLY JOIN CD3 AND / OR CD123
PE20170665A1 (en) HUMANIZED ANTI-TAU ANTIBODIES
MX2024009271A (en) Optimized nucleic acid antibody constructs.
PH12021550244A1 (en) Anti-btla antibody
NI201800113A (en) HUMANIZED ANTI-BASIGIN ANTIBODIES AND THE USE OF THEM.
AR101555A1 (en) ANTIBODIES DIRECTED TO THE Fc g RECEIVER IIB AND THE Fc e RECEIVER
EA201992315A1 (en) COMPOSITIONS AND METHODS FOR TREATING LUNG CANCER
NZ731491A (en) Cd83 binding proteins and uses thereof
EA202090864A1 (en) MONOCLONAL ANTIBODY TO IL-5R
AR126090A2 (en) ANTIBODY OR FRAGMENT BINDING TO THE ANTIGEN OF THIS, DNA MOLECULE, CLONING OR EXPRESSION VECTOR AND HOST CELL
JOP20210100A1 (en) Monoclonal antibody that specifically binds to cd20
EA202092334A1 (en) C-TERMINAL ANTIBODIES
UY37915A (en) SPECIFIC ANTIBODIES FOR CD47 AND PD-L1
EA202090901A1 (en) MULTI-SPECIFIC ANTIBODY